What happens when a Silicon Valley entrepreneur, a synthetic biology expert, and a world-renowned cancer researcher team up? They create Earli—a startup rewriting the rules of cancer detection and treatment.
Does it really matter how diversified your portfolio is if you can’t handle your emotions when the market starts crashing and your assets are losing value?